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ASSOCIATION STUDIES
By Ruth Heller1 and Daniel Yekutieli
Tel-Aviv University
The paramount importance of replicating associations is well rec-
ognized in the genome-wide associaton (GWA) research community,
yet methods for assessing replicability of associations are scarce. Pub-
lished GWA studies often combine separately the results of primary
studies and of the follow-up studies. Informally, reporting the two
separate meta-analyses, that of the primary studies and follow-up
studies, gives a sense of the replicability of the results. We suggest a
formal empirical Bayes approach for discovering whether results have
been replicated across studies, in which we estimate the optimal rejec-
tion region for discovering replicated results. We demonstrate, using
realistic simulations, that the average false discovery proportion of
our method remains small. We apply our method to six type two
diabetes (T2D) GWA studies. Out of 803 SNPs discovered to be as-
sociated with T2D using a typical meta-analysis, we discovered 219
SNPs with replicated associations with T2D. We recommend com-
plementing a meta-analysis with a replicability analysis for GWA
studies.
1. Introduction. The aim of a genome-wide association (GWA) study
is to identify genetic variants that are associated with a given phenotype.
An analysis that combines several GWA studies of the same phenotype may
have increased power to discover the genetic variants that are associated
with the phenotype. Such a meta-analysis combines all the data from all
the studies to compute an overall p-value for each SNP. The overall p-values
are used to identify the loci that are associated with the disease. A seminal
example of combining data to identify association comes from the field of
type 2 diabetes (T2D) GWAS. Voight et al. (2010) discover in a meta-
analysis single nucleotide polymorphisms (SNPs) associated with T2D that
were not discovered in single studies.
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The paramount importance of replicating associations has been well rec-
ognized in the GWAS literature [e.g., McCarthy et al. (2008), NCI-NHGRI
(2007)]. Kraft, Zeggini and Ioannidis (2009) note that for common vari-
ants, the anticipated effects are modest and very similar in magnitude to
the subtle biases that may affect genetic association studies—most notably
population stratification bias. For this reason, they argue that it is impor-
tant to see the association in other studies conducted using a similar, but
not identical, study base. Ioannidis and Khoury (2011) discuss multiple steps
needed to validate “omics” findings, including “replication,” which they de-
fine as the step to answer the question “Do many different data sets and
their combination (meta-analysis) get consistent results?”
Meta-analysis of several GWA studies aims to discover the associations
that are present in at least one study, not replicated associations. We define
replicability analysis as an analysis with the aim to discover replicated asso-
ciations, that is, associations between SNP and phenotype that are present
in more than one of the studies. Meta-analysis methods are not appropri-
ate for discovering replicated associations. To see this, consider the scenario
where for testing the null hypothesis that a SNP is independent of the phe-
notype, the p-value is extremely small in one study, but not small at all in
the other studies. The meta-analysis will result in a small combined p-value,
since there is evidence of association of this SNP with the phenotype, but
there is no evidence that this association is replicated. Therefore, a small
p-value in a typical meta-analysis is evidence toward association of the SNP
with the phenotype in at least one study, but it is not evidence that the
association has been replicated in more than one study.
Many methods exist for meta-analysis, where follow-up studies simply
serve to add power. See Hedges and Olkin (1985), Benjamini and Yekutieli
(2005), Skol et al. (2006) and Zeggini et al. (2007), among others. How-
ever, only a handful of methods have been suggested so far for replicability
analysis. Benjamini, Heller and Yekutieli [(2009); hereafter, BHY09] sug-
gest applying the Benjamini–Hochberg procedure [Benjamini and Hochberg
(1995)], henceforth referred to as the BH procedure, on partial conjunction
hypotheses p-values introduced in Benjamini and Heller (2008). Bogomolov
and Heller (2013) focus on replicability analysis for two studies, and sug-
gest an alternative false discovery rate (FDR) controlling procedure for this
setting. Natarajan, Pu and Messer (2012) suggest a list-intersection test to
compare the top-ranked gene lists from multiple studies in order to discover
a common significant set of genes. In this work, we suggest an empirical
Bayes approach to replicability analysis. This approach may be viewed as
an extension of the empirical Bayes approach of Efron (2008). We estimate
the local Bayes FDRs under the various configurations of association sta-
tus of SNP with phenotype across studies, and then sum up the relevant
probabilities in order to estimate the Bayes FDR.
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The motivating example for this work came from the field of T2D GWA
studies and, therefore, we discuss this work in the context of GWA studies.
However, the proposed approach is a general approach for assessing repli-
cability in several studies when each study examines the same hypotheses.
Section 2 describes the motivating example and defines formally our replica-
bility analysis aim. In Section 3 we present the empirical Bayes method, and
in Section 4 we apply the method to the motivating example. In Section 5 we
use simulations to evaluate the performance of our method. We show that
in realistic simulations, the average false discovery proportion (FDP) of our
method remains small, while the power is much greater than the power of the
method of BHY09. A similar observation was made in Sun and Wei (2011),
where the advantage of using an empirical Bayes approach to testing sets of
hypotheses over the method of Benjamini and Heller (2008) was illustrated
by an application to time-course microarray data. We conclude with a brief
summary in Section 6.
2. Motivating example and formulation of the replicability analysis aims.
Voight et al. (2010) conducted a meta-analysis of eight T2D GWA studies
comprising 8130 T2D cases and 38,987 controls of European descent. They
combined the case-referent data from the Wellcome Trust Case Control Con-
sortium (WTCCC), the Diabetes Genetics Initiative (DGI), the Finland-US
Investigation of NIDDM genetics (FUSION) scans, deCode genetics (DE-
CODE), the Diabetes gene Discovery Group, the Cooperative Health Re-
search in the Region of Augsburg group, the Rotterdam study (ERGO) and
the European Special Populatin Research Network (EUROSPAN). Based on
a meta-analysis of these studies, Voight et al. (2010) selected a few dozen
SNPs for follow-up, and reported the SNPs that had a small p-value in the
follow-up study, saying that these SNPs showed, in their words, “strong
evidence for replication.”
We received permission to use the p-values for the following six stud-
ies used for meta-analysis in Voight et al. (2010): EUROSPAN, DECODE,
ERGO, DGI, FUSION and WTCCC. For these six studies, our aim was
to discover the SNPs that show strong evidence for replication of associa-
tion with T2D within a formal statistical analysis framework. Replication
of association can be defined in several ways: with or without regard to the
direction of association; with at least u out of the six studies showing associ-
ation, where u ∈ {2, . . . ,6} is fixed in advance. Since direction consistency is
typically sought between the primary and follow-up studies in GWAS [e.g.,
Voight et al. (2010)], our definition takes the directionality into account.
For the six studies, we consider a SNP as having a replicated association if
there is enough evidence to establish that the association of SNP with the
phenotype is in the same direction in at least two studies.
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In order to define the replicability aim formally, we use the following
notation. Suppose there are n independent studies, and in each study M
SNPs are measured. For SNP j in study i, define Hij as follows:
Hij =

1, if SNP j is positively associated with the phenotype in study i,
0, if SNP j is not associated with the phenotype in study i,
−1, if SNP j is negatively associated with the phenotype in study i.
Let Tij be the test statistic of SNP j in study i. Following Efron (2010),
rather than computing the p-value, we transform the test statistic into a z-
score Zij =Φ
−1(Fi0(Tij)), where Fi0 is the cumulative distribution functions
for Tij when Hij = 0 and Φ
−1 is the inverse of the standard normal cumula-
tive distribution function, respectively. The conditional density of Zij given
Hij is
f(z|Hij) =

fi,1(z), if Hij = 1,
f0(z), if Hij = 0,
fi,−1(z), if Hij =−1,
where f0(z) is the standard normal density.
Let H = {~h= (h1, . . . , hn) :hi ∈ {−1,0,1}} be the set of 3
n possible con-
figurations of the vector of association status (of SNP with phenotype) in
the n studies. We are interested in examining null hypotheses for the n
studies that are defined by subsets of H denoted by H0. In particular, we
shall examine the no association null hypothesis H0NA that the SNP is not
associated with the phenotype in any of the studies,
H0NA :{(0,0, . . . ,0)}
as well as the no replicability null hypothesis H0NR that the SNP is positively
and negatively associated with the phenotype in at most one study,
H0NR :
{
~h :
n∑
i=1
I(hi =−1)≤ 1∩
n∑
i=1
I(hi = 1)≤ 1
}
,
where I(·) is the indicator function.
Our primary goal in this work is to discover as many SNPs as possi-
ble with false H0NR. This goal is distinct from the meta-analysis goal of
discovering as many SNPs as possible with false H0NA. For example, for
n = 2 studies, H contains 32 = 9 configurations, H0NA = {(0,0)},H
0
NR =
{(0,0), (1,0), (0,1), (−1,0), (0,−1), (1,−1), (−1,1)}, and we aim to discover
as many SNPs from the index set {j : ~Hj ∈H/H
0
NR}, whereH/H
0
NR = {(1,1),
(−1,−1)}. Had we defined replicability without taking directionality into
account, the null hypothesis of interest would have been H0 = {(0,0), (1,0),
(−1,0), (0,1), (0,−1)}, which aims to discover as many SNPs as possible
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from the index set {j : ~Hj ∈ {(1,1), (−1,−1), (−1,1), (1,−1)}}. This aim could
be pursued just as easily as the aim that follows from our definition of repli-
cability, with the analysis method of the next Section 3, but we do not
examine it here.
3. The empirical Bayes approach to replicability analysis.
3.1. The empirical Bayes approach to multiple testing. The two group
model provides a simple Bayesian framework for multiple testing; see, for
example, Chapter 2 in Efron (2010). Each SNP in study i has marginal prob-
ability π0(i) of not being associated with the phenotype, that is, Pr(Hij =
0) = π0(i). Conditional on Hij = 0, the SNP has a standard normal density,
f0(z). Unconditionally, the continuous marginal (mixture) density is fi(z).
For a subset Z of ℜ, let P0(Z) =
∫
Z f0(z)dz and Pi(Z) =
∫
Z fi(z)dz.
Suppose we observe zij ∈ Z and wish to test Hij = 0. A direct application
of Bayes’ theorem yields
Fdri(Z) = Pr(Hij = 0|zij ∈ Z) = π0(i)P0(Z)/Pi(Z).
Adopting the terminology in Efron (2010), we call Fdri(Z) the Bayes FDR
for Z : if we report zij ∈ Z as nonnull, that is, if we report Hij 6= 0, then
Fdri(Z) is the chance that we have made a false discovery, that is, that
Hij = 0.
Theorem 1 of Storey (2003) shows that for the two group model for in-
dependent test statistics, Fdri(Z) is closely connected to the FDR intro-
duced in Benjamini and Hochberg (1995). Let Hi = (Hi1, . . . ,HiM ),Zi =
(Zi1, . . . ,ZiM ),Q(Z,Hi) =
∑M
j=1 I(zij ∈Z,Hij = 0)/max(Ri,1), whereRi =∑M
j=1 I(zij ∈Z) is the number of z-scores in the rejection region. The FDR
is FDR(Z,Hi) =EZi|HiQ(Z,Hi). Taking expectation over the random Hi,
EHi [FDR(Z,Hi)] = Pr(Ri > 0)EZi,Hi [Q|Ri > 0] = Pr(Ri > 0)Fdri(Z).
If Z is a single point z0, then the local Bayes FDR is
fdri(z0) = Pr(Hij = 0|zij = z0) = π0(i)f0(z0)/fi(z0).
Fdri(Z) is the conditional expectation of fdri(z) given z ∈ Z [Efron and
Tibshirani (2002)],
Fdri(Z) =Efi(fdri(z)|z ∈Z).(3.1)
The Bayes false negative rate is Fnri(Z) = Pr(Hij 6= 0|zij /∈ Z) [Efron
(2010)]. Similar to Storey (2007) and Sun and Cai (2007), we observe that
among all possible rejection regions Z constrained to satisfy that Fdr(Z)≤
q, the region with maximal probability, and with minimal Bayes false nega-
tive rate, will be of the form
ZOR = {z :fdri(z)≤ t(q)}.(3.2)
The result is stated formally in the following proposition.
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Proposition 3.1. Assume the two group model holds for the z-scores
in study i. Let t(q) in expression (3.2) be such that Fdri(ZOR) = q. For any
Z satisfying Fdri(Z)≤ q,
1. Pi(Z)≤ Pi(ZOR).
2. Fnri(ZOR)≤ Fnri(Z).
See the proof in Section 1 of the supplementary material [Heller and
Yekutieli (2014)].
In the two group model, π0(i) and fi are needed in order to compute the
local Bayes FDR. These quantities are estimated in the R package locfdr,
available on CRAN. Poisson regression is used to estimate the marginal
density of the z-scores, fˆi. The assumption that z-scores that fall in the
range of the central 50% of the null distribution are null is used to estimate
the fraction of null hypotheses: πˆ0(i) =
|{j : zij∈[Φ−1(0.25),Φ−1(0.75)]}|
M×0.5 . Other
estimation methods are suggested in Strimmer (2008), Muralidharan (2010),
Storey and Tibshirani (2003), Benjamini, Krieger and Yekutieli (2006) and
Jin and Cai (2007).
For a rejection region Z , equation (3.1) shows that Fdri(Z) may be esti-
mated by
F̂ dri(Z) =
∑
j : zij∈Z
f̂ dr(zij)
|{j : zij ∈ Z}|
,
where f̂ dri(zij) = πˆ0(i)f0(zij)/fˆi(zij) is the estimated local Bayes FDR of
z-score zij , and |{j : zij ∈ Z}| is the number of z-scores in Z . The esti-
mated optimal rejection region is Z = {zij : f̂ dri(zij) ≤ t(q)}, where t(q) is
the largest threshold so that F̂ dri(Z) is at most q.
3.2. Generalization of the two group model. Each SNP has probability
π(~h) of having association configuration ~h, that is, Pr( ~Hj = ~h) = π(~h). We
assume the z-scores are independent across studies conditional on the as-
sociation status ~Hj = ~h, so the vector of n z-scores ~zj = (z1j , . . . , znj) has
density f(~zj|~h) =
∏n
i=1 f(zij|hi). Note that π0(i) is equal to the sum of the
probabilities π(~h) over all 3n−1 configurations ~h ∈H with hi = 0.
Suppose we observe ~zj for SNP j and wish to test ~Hj ∈ H
0. A direct
application of Bayes’ theorem yields the local Bayes FDR
fdrH0(~zj) = Pr( ~Hj ∈H
0|~zj) =
∑
~h∈H0
π(~h)f(~zj |~h)/f(~zj),(3.3)
where f(~zj) =
∑
~h∈H
π(~h)f(~zj |~h) is the mixture density. The local Bayes
FDR for SNP j for null hypothesis H0NA and H
0
NR, respectively, is
fdrH0NA
(~zj) = Pr( ~Hj ∈H
0
NA|~zj) and fdrH0NR
(~zj) = Pr( ~Hj ∈H
0
NR|~zj).
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For a subset Z of ℜn, if we report for ~zj ∈Z that ~Hj /∈H
0, then the Bayes
FDR is, as in equation (3.1),
FdrH0(Z) = Pr( ~Hj ∈H
0|~zj ∈ Z) =Ef (fdrH0(~zj)|~zj ∈ Z).(3.4)
The optimal rejection region to discover SNPs that are nonnull, that is,
~Hj /∈H
0, follows from the same optimality argument of Proposition 3.1. The
rejection region with maximal probability and minimal Bayes false negative
rate among all possible rejection regions that are constrained to have a Bayes
FDR of at most level q is
ZOR,H0 = {~z :fdrH0(~z)≤ t(q)},(3.5)
where t(q) is such that FdrH0(ZOR,H0) = q. Section 2 of the supplemen-
tary material [Heller and Yekutieli (2014)] shows numerical examples that
demonstrate the different optimal rejection regions for no replicability null
hypotheses and for no association null hypotheses, as well as the loss in
power that occurs when the rejection region is chosen suboptimally based
on p-values.
To test whether ~Hj ∈ H
0 on the n studies, we need to first estimate
the local Bayes FDR for the observed z-scores, {f̂ drH0(~zk) :k = 1, . . . ,M}.
We use these estimates to estimate the Bayes FDR (3.4) for every z-score
~zj (j = 1, . . . ,M):
F̂ drH0(Zj) =
∑
k:~zk∈Zj
f̂ drH0(~zk)
|{k :~zk ∈ Zj}|
,(3.6)
where Zj = {~zk : f̂ drH0(~zk)≤ f̂ drH0(~zj), k = 1, . . . ,M}. Let tˆ(q) be the largest
estimated local Bayes FDR satisfying F̂ dr(Zj) ≤ q. Then, our estimate of
the optimal rejection region (3.5) is {~zk : f̂ drH0(~zk) ≤ tˆ(q), k = 1, . . . ,M}.
We conclude that SNP k is nonnull, that is, ~Hk /∈ H0, if f̂ drH0(~zk) ≤ tˆ(q)
or, equivalently, if F̂ dr(Zk)≤ q.
To compute f(~zj), it is necessary to specify the conditional distributions
for the three states of nature for association for each SNP in each study:
Hij ∈ {−1,0,1}. This is a key difference from the analysis of single studies,
where estimation of the marginal density of the z-scores does not require
estimation of the conditional distributions. In Section 3 of the supplemen-
tary material [Heller and Yekutieli (2014)] we demonstrate the necessity of
estimating the conditional distributions for the states Hij =−1 and Hij = 1
in order to get a good estimate of f(~zj) at the tails, for ~Hj with dependent
components.
Next, we show how to estimate π(~h) and the conditional z-score densities
that are necessary for estimating the local Bayes FDR.
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3.3. Estimating π(~h) and the conditional z-score densities. The likeli-
hood for the z-scores for SNP j is
L(~π;~zj, f) = Pr(~zj |~π) =
∑
~h∈H
f(~zj|~h)π(~h),(3.7)
where ~π = {π(~h) :~h ∈H,
∑
~h∈H
π(~h) = 1} is the set of 3n − 1 probabilities of
the multi-group model we want to estimate.
The full likelihood requires both the joint distribution of ( ~H1 · · · ~HM) and,
for each study i (i= 1, . . . , n), the joint distribution of (Zi1, . . . ,ZiM ) given
(Hi1, . . . ,HiM ). Since the joint distribution is unknown, we consider instead
the composite likelihood, which is the product of the marginal likelihoods
for the M SNPs,
LCL(~π;~z, f) =
M∏
j=1
L(~π;~zj, f).
Although the composite likelihood is different than the full likelihood, in
large problems with local dependency the maximum likelihood estimates of
the composite likelihood and the full likelihood are very similar [Cox and
Reid (2004)]. For GWAS the assumption of local dependency seems reason-
able, since the dependency across SNPs diminishes as the distance between
the SNPs increases. In Section 5 we verified that the composite likelihood
was indeed appropriate using simulated data with GWA dependency.
Assuming that the probabilities in ~π were known, the composite likeli-
hood could be computed if the probability distributions of zij given Hij ∈
{−1,0,1}, i = 1, . . . , n, were known, since f(~zj| ~Hj) =
∏n
i=1 fi,Hij(zij). Con-
ditional on Hij = 0, the density of zij , denoted by f0(·), is indeed known
to be standard normal [in Section 6 we discuss what can be done when
f0(·) is unknown]. Mixture model density estimation methods can be used
to estimate fi,1 and fi,−1 [McLachlan and Peel (2000)]. First, the methods
discussed in Section 3.1 can be used to estimate the marginal density of the
z-scores for each study, fi, and the fraction of SNPs with no association
with the phenotype, π0(i). Denoting the estimates by fˆi and πˆ0(i), the bi-
modal alternative density is fˆi,A(z) =
fˆi(z)−πˆ0(i)f0(z)
1−πˆ0(i)
. Next, the expectation
maximization (EM) algorithm, detailed in Section 4 of the supplementary
material [Heller and Yekutieli (2014)], is used to find ~π that maximizes the
composite likelihood.
4. Replicability analysis of T2D GWA studies. Our first step in this anal-
ysis is to estimate the fraction of null hypotheses for each of the six studies,
using the locfdr package. In two of the studies, the estimated fraction of null
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hypotheses is 1. Since a stable estimate of the conditional distribution un-
der the alternative could not be extracted for these two studies, we excluded
them from the empirical Bayes analysis. Studies DECODE, DGI, FUSION
and WTCCC had estimated fractions of null hypotheses of 0.89, 0.98, 0.98
and 0.96, respectively. Figure 1 of the supplementary material [Heller and
Yekutieli (2014)] shows the histogram of z-scores, as well as the estimated
conditional densities, for each of the six studies, as outputted from the locfdr
package.
Binning of z-scores. In the locfdr package, the z-scores are binned before
the densities are estimated. Binning is practical in our application since
in the estimation of the local Bayes FDRs for several studies, estimated
conditional densities are multiplied. The accuracy of multiplied estimates
may be far less stable without binning. Therefore, we first divide the z-scores
{zij : j = 1, . . . ,M} into B bins of equal width. For this application, we tried
both B = 50 and B = 120 and received similar results. Let xi,1 · · ·xi,B be
the centers of these bins. We assign each z-score zij into the bin that it is
in, denoted by z˜ij ∈ {1, . . . ,B}. For SNP j, the probability of the vector of
n binned z-scores z˜j = (z˜1j , . . . , z˜nj) given configuration ~Hj is f˜(z˜j | ~Hj) =∏n
i=1 f˜i,Hij(z˜ij), where f˜i,Hij(b) =
fi,Hij (xi,b)
∑B
l=1 fi,Hij (xi,l)
. For Hij = 0, f0(xi,b) is the
standard normal density at point xi,b. For Hij ∈ {−1,1},
fi,1(xi,b) =
{
0, if xi,b ≤ 0,
fˆA(xi,b), if xi,b > 0,
and
fi,−1(xi,b) =
{
0, if xi,b ≥ 0,
fˆA(xi,b), if xi,b < 0.
The EM algorithm was used to find ~π that maximizes the composite likeli-
hood on the binned z-scores,
∏M
j=1
∑
~h∈H
f˜(z˜j |~h)π(~h).
For n = 4 studies, the sets H and H0NR contain, respectively, 81 and 21
configurations, and H0NA contains only the configuration (0,0,0,0). The em-
pirical Bayes analysis at level q = 0.05 discovered 803 SNPs associated with
T2D and 219 SNPs with replicated association with T2D. A list of the 219
SNPs with replicated associations discovered by the empirical Bayes anal-
ysis, sorted by positions on the chromosome, is given in Section 5 of the
supplementary material [Heller and Yekutieli (2014)]. SNPs with replicated
association included 16 distinct genes. We extracted the SNP with smallest
estimated local Bayes FDR among all SNPs within each of these 16 genes, as
well as among all SNPs in noncoding areas. In Table 1 we list these 17 SNPs,
along with the estimated Bayes FDR for replicability analysis (column 5)
and for the analysis to discover association in (column 6). As expected, the
estimated Bayes FDR is larger for replicability analysis than for an analysis
to discover associations, and the ranking for replicability is different than
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for discovering associations. For example, the empirical Bayes analysis for
KIF11 ranks it 7th for evidence of replicability but 5th for evidence of as-
sociation; KCNJ11 is ranked 5th for evidence of replicability but 8th for
evidence of association. The SNP which has by far the strongest evidence
of association, and replicated association, is in TCF7L2. This association
has been well established in previous papers [Voight et al. (2010)]. The very
small estimated Bayes FDRs for this SNP are a result of compounding the
strong evidence against the null from four studies.
As a comparison procedure, we considered the replicability analysis sug-
gested in BHY09, which was to apply the BH procedure on the M no repli-
cability null hypotheses p-values, computed as suggested in Benjamini and
Heller (2008). We applied the analysis suggested in BHY09 on the n = 4
studies with estimated fraction of null hypotheses below one, as well as on
all the n= 6 studies available. Briefly, the recipe for computing p-values for
the no replicability null hypotheses was as follows. First, for every subset
of n− 1 studies, a meta-analysis p-value was computed. Then, the p-value
for the no replicability null hypothesis was set to be the maximum of the n
meta-analysis p-values. Since we considered in this work a concordant ver-
sion of replicability, where the association was considered replicated only if
it was present in at least two studies in the same direction, the p-value was
taken to be twice the smaller of the left- and right-sided combined p-values
using the method of Fisher, as suggested in Owen (2009).
The replicability analysis of BHY09 at level q = 0.05 based on the four
studies discovered 447 SNPs associated with T2D and 83 SNPs with repli-
cated association with T2D, and based on the six studies discovered 466
SNPs associated with T2D and 113 SNPs with replicated association with
T2D. Table 1 shows the adjusted p-values based on all six available studies
in columns seven and eight, respectively. While the meta-analysis of BHY09
indicates that there is evidence of association in almost all these regions,
evidence of replicated association is inferred only for five regions.
The empirical Bayes approach provides for each SNP a measure of be-
lief in each possible configuration ~h, conditional on its vector of z-scores.
For example, the vector of z-scores for SNP rs7903146 in gene TCF7L2
was ~z = (−8.8,−4.5,−4.4,−7.5) in studies DECODE, DGI, FUSION and
WTCCC, respectively. The estimated posterior probability was 0.98 that
the configuration was ~h = (−1,−1,−1,−1), conditional on the binned z-
score vector. The vector of z-scores for SNP rs10923931 in gene NOTCH2
was ~z = (−3.4,−4.9,−0.12,−2.8) with estimated posterior probability 0.92
for configuration ~h= (−1,−1,0,−1). Table 2 shows the estimated posterior
probability distributions for these two SNPs.
5. Simulation studies. If all parameters were known, the optimal rejec-
tion region could be calculated. In Section 2 of the supplementary material
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Table 1
For the SNPs with strongest evidence toward replicability in 17 distinct regions discovered
by the empirical Bayes replicability analysis: the estimated Bayes FDR for replicability
and for association (column 5–6); the adjusted p-values from the analysis of BHY09 for
replicability and for association (column 7–8)
Empirical Bayes Fdr BHY09 adjusted p-values
chr pos Gene Replicability Association Replicability Association
rs7903146 10 114758349 TCF7L2 2.40e–11 4.61e–22 0.00e+00 0.00e+00
rs10440833 6 20688121 CDKAL1 1.60e–05 8.06e–08 9.06e–09 0.00e+00
rs5015480 10 94465559 noncoding 1.10e–03 7.74e–05 8.78e–04 1.12e–07
rs4402960 3 185511687 IGF2BP2 3.14e–03 6.87e–04 0.0205 3.51e–05
rs5215 11 17408630 KCNJ11 8.91e–03 4.50e–03 1.00e+00 0.0236
rs757110 11 17418477 ABCC8 9.98e–03 6.16e–03 1.00e+00 0.0267
rs4933734 10 94414567 KIF11 0.0111 2.96e–04 1.00e+00 1.55e–05
rs10923931 1 120517959 NOTCH2 0.0134 2.70e–03 1.00e+00 3.45e–04
rs11187033 10 94262359 IDE 0.0189 2.07e–03 0.0186 7.07e–06
rs319602 5 134222164 TXNDC15 0.0202 7.07e–03 1.00e+00 0.0364
rs849134 7 28196222 JAZF1 0.0210 7.80e–03 9.84e–01 1.16e–03
rs6883047 5 134272055 PCBD2 0.0235 8.55e–03 1.00e+00 0.0471
rs10832778 11 17394073 B7H6 0.0282 0.0164 1.00e+00 1.53e–01
rs13070993 3 12217797 SYN2 0.0370 0.0235 1.00e+00 0.0369
rs10433537 3 12198485 TIMP4 0.0360 0.0233 1.00e+00 0.0386
rs10113282 8 96038252 C8orf38 0.0387 0.0102 1.00e+00 0.0408
rs1554522 17 25913172 KSR1 0.0436 0.0145 1.00e+00 2.13e–01
Table 2
The estimated posterior probabilities for different configurations ~h, conditional on the
binned z-score of ~z, for two example z-scores: rs7903146 in gene TCF7L2 (column 2)
and rs10923931 in gene NOTCH2 (column 3)
~h ~z = (−8.8,−4.5,−4.4,−7.5) ~z = (−3.4,−4.9,−0.12,−2.8)
(−1,−1,−1,−1) 0.980 0.000
(−1,−1,0,−1) 0.012 0.924
(−1,−1,0,0) 0.000 0.047
(−1,0,−1,−1) 0.008 0.000
(−1,0,0,−1) 0.000 0.004
(0,−1,0,−1) 0.000 0.024
(0,−1,0,0) 0.000 0.001
[Heller and Yekutieli (2014)], we present two simple examples that demon-
strate the difference between the optimal rejection region for a replicability
analysis and that for an analysis to discover associations, and show that the
optimal region can be much larger than that based on p-values. Since the
optimal rejection region has to be estimated in practice, we examine here
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the empirical Bayes approach that estimates the optimal rejection region
for inference. Specifically, the goal of the simulations was twofold: First, to
investigate the effect of the number of SNPs M , and the dependence across
SNPs, on the empirical Bayes procedure; Second, to compare the empirical
Bayes procedure to the replicability analysis of BHY09 at the same level q.
In the empirical Bayes analysis, the z-scores were first binned, using B = 50
bins, and SNPs were considered discovered if the estimated Bayes FDR in
equation (3.6) was below q = 0.05. In addition to the empirical Bayes proce-
dure that estimates ~π via the EM algorithm, we also considered the oracle
Bayes procedure that knows the association status Hij of each SNP. The
oracle Bayes procedure estimates the conditional probabilities of the binned
z-scores in each study by the relative frequency of each bin conditional on
the association status, and uses the true vector ~π for computing the local
Bayes FDRs.
5.1. Independence within each study. We considered n= 3 studies, with
2000 cases and 2000 referents and M ∈ {103,104,105} SNPs in each study.
Although there were 3n = 27 possible configurations of the vector of associ-
ations status, our data generation process had positive probability only for
the 15 configurations that do not have a positive and negative association
for the same SNP: configuration (0,0,0) for 90% of the SNPs; the six con-
figurations with exactly one true association, that is, ~Hj s.t.
∑3
i=1 |Hij |= 1,
each for 1% of the SNPs; the eight configurations with at least two true
associations in the same direction, that is, ~Hj s.t. |
∑3
i=1Hij| ≥ 2, each for
0.5% of the SNPs. Following Wakefield (2007), we simulated data for every
SNP independently with disease risk, pij , given by the logistic regression
model logit(pij) = α+uθij , where u= 0,0.5, and 1 corresponds to 0,1 and 2
copies of the mutant allele, respectively. We sample θij given Hij as follows:
θij |Hij ∼

U(0.25,0.5), if Hij = 1,
0, if Hij = 0,
U(−0.5,−0.25), if Hij =−1,
where U(a, b) denotes the uniform distribution between a and b. Moreover,
the minor allele frequency (MAF) for each SNP j in study i was sampled
from U(0.05,0.50), and we set α=−6, so eα = 0.0025 was the prior odds of
a disease due to a SNP with u= 0.
Results. The simulation results were based on 50 repetitions for M =
105, and on 100 repetitions for M = 104 and M = 1000. Figure 2 in the
supplementary material [Heller and Yekutieli (2014)] shows the FDP in an
analysis to discover associations and in a replicability analysis. The variation
in FDP decreases withM and is very small forM = 105. Table 3 presents the
average FDP and number of rejections, R. Although the average FDP of the
REPLICABILITY ANALYSIS FOR GWAS 13
Table 3
The average FDP and number of rejections R in an empirical Bayes analysis (columns 3
and 6), in the analysis of BHY09 (columns 4 and 7) and in an oracle Bayes analysis
(columns 5 and 8), for different values of M = number of hypotheses
FDP (SE× 1000) R (SE)
Analysis Empirical Oracle Empirical Oracle
type M Bayes BHY09 Bayes Bayes BHY09 Bayes
Replicability 105 0.049 (1) 0.001 (0) 0.050 (1) 2040.6 (6.3) 684.1 (3.4) 2091.6 (4.8)
104 0.049 (2) 0.000 (0) 0.049 (1) 203.6 (1.4) 68 (0.9) 211.2 (1.1)
103 0.071 (6) 0.000 (0) 0.044 (4) 20.5 (0.4) 7.1 (0.3) 22.7 (0.3)
Association 105 0.046 (0) 0.039 (0) 0.050 (0) 5911.3 (8.7) 5495.8 (7.8) 6047.0 (9.3)
104 0.047 (1) 0.038 (1) 0.050 (1) 591.3 (1.7) 549.7 (1.8) 610.6 (1.8)
103 0.051 (2) 0.040 (3) 0.045 (2) 58.7 (0.6) 54.9 (0.6) 66.6 (0.5)
empirical Bayes analysis was below 0.05 forM ≥ 104, the average FDP when
M = 1000 was 0.071, with a standard error (SE) of 0.006. The empirical
Bayes analysis makes only a few more discoveries than the analysis of BHY09
when the aim is to discover associations, but threefold more discoveries when
the aim is to discover replicated associations. For example, forM = 105 SNPs
the empirical Bayes analysis discovers on average 2040 SNPs with replicated
associations, while the analysis of BHY09 discovers only an average of 684
SNPs. A comparison of columns 6 and 8 shows that the oracle Bayes analysis
produces only a few more discoveries than the empirical Bayes analysis,
suggesting that the loss of power in the estimation of the parameters is
small.
Remark 5.1. Table 3 shows that the average FDP for the analysis of
BHY09 when the aim is to discover associations was lower than π(0,0,0)×
0.05 = 0.045. For example, for M = 105 the average FDP was 0.039. This is
due to the discreteness of the distribution of the p-values that were computed
from contingency tables. Indeed, when the sample size was tripled, the p-
values from true no association null hypotheses were closer to uniform and,
therefore, the average FDP was closer to the nominal level (not shown).
However, the over-conservativeness of the replicability analysis remained
severe when the sample size was tripled.
5.2. GWA dependency within each study. We simulated three GWA stud-
ies from the simulator HAPGEN2 [Su, Marchini and Donnelly (2011)]. The
three studies where generated from three samples of the HapMap project
[The International HapMap Consortium (2003)]: a sample of 87 individuals
with African ancestry in Southwest USA (ASW), a sample of 165 Utah resi-
dents with Northern andWestern European ancestry (CEU), and a sample of
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109 Chinese in Metropolitan Denver, Colorado (CHD). We limited ourselves
to chromosomes 1–4, that contained M = 415,154 SNPs. In these popula-
tions, the number of causal SNPs was 26 for ASW, 22 for CEU and 27 for
CHD. Since the effects are typically small for GWA studies, we consider for
each population four subpopulations, and within each subpopulation about
1/4 of the causal SNPs had an increased multiplicative relative risk of 1.5.
Overall, there were 48 different causal SNPs in the four chromosomes, out
of which 22 SNPs were causal in more than one population. Specifically, the
three populations had five causal SNPs in common and, in addition, the
number of causal SNPs in common in exactly two of the three populations
was as follows: four for ASW and CEU, seven for ASW and CHD, and six
for CEU and CHD. Each study contained 8000 cases and 8000 referents from
each population. The simulator HAPGEN2 uses an estimate of the fine-scale
recombination rate map to simulate haplotypes conditional on the reference
haplotype data from the HapMap project. The simulator assumes a hidden
Markov model and treats the recombination rates and mutation rates as
transition and emission probabilities, respectively. The resulting simulated
data has the same linkage disequilibrium (LD) patterns as each reference
data from the HapMap project.
Due to LD, the number of SNPs associated with the phenotype in every
study was larger than the number of causal SNPs. Since it is not known
from the data generation process which SNPs are associated with the phe-
notype in each study, then for a noncausal SNP j we do not know whether
H0 ∈ {H0NA,H
0
NR} is false, since noncausal SNPs may have false H
0 due to
LD patterns in the different populations. Since a major goal in the simula-
tions was to assess whether the FDP is inflated, it was necessary to establish
a ground truth. We wanted to estimate a conservative ground truth that with
very high probability estimates a SNP as having a true H0 if indeed it is
from H0, at the possible expense of estimating a SNP as having a true H0
even if H0 was false. The estimation of the ground truth was as follows.
The simulation studies were repeated 20 times, resulting in 20 p-values per
population for every SNP. The 20 p-values were first combined with Fisher’s
combining method, and the analysis of BHY09 was applied to the combined
p-values from the three populations, to form for each SNP a combined p-
value for H0 ∈ {H0NA ,H
0
NR} that is based on 20 studies per population. H
0
was considered to be false for a SNP if the p-value for testing H0 was below
the severe Bonferroni threshold for FWER control at level 0.05. The result-
ing ground truth contains 2126 SNPs associated with the phenotype, that is,
with false H0NA, and 695 SNPs with replicated association with the pheno-
type, that is, with false H0NR. The ground truth based on 20 repetitions was
very similar to a ground truth that was established based on only 19 of the
20 repetitions and, therefore, for an analysis of one repetition, the resulting
FDP using the ground truth based on 20 repetitions was very similar to the
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Table 4
The average FDP, and number of rejections R, in an empirical Bayes analysis (columns
2 and 4) and in the analysis of BHY09 (columns 3 and 5), for the simulated data with
GWA dependency within each study
FDP (SE× 1000) R (SE)
Analysis type Empirical Bayes BHY09 Empirical Bayes BHY09
Replicability 0.065 (9) 0.000 (0) 154.1 (8.5) 6.4 (1.2)
Association 0.072 (9) 0.053 (5) 274.9 (12.4) 242.7 (10.4)
FDP using the ground truth that results from the 19 repetitions excluding
the repetition being analyzed.
Results. Table 4 shows the analysis results for the 20 repetitions of the
three studies. Although the average number of rejections was only slightly
larger with the empirical Bayes analysis than with the analysis of BHY09
for testing associations, it was more than 20 times larger when testing for
replicated associations. The average FDP for the empirical Bayes analysis
was slightly above the nominal level of 0.05, possibly because either “ground
truth” was too conservative (“false rejections” are not really “false”) or the
empirical Bayes analysis is indeed slightly anti-conservative for the type
of dependency that occurs in GWA studies. Nevertheless, this simulation
demonstrates the large gain in using an empirical Bayes analysis over the
analysis of BHY09 for discovering replicated associations. This large gain
comes at a small risk, slightly inflated FDR.
6. Summary. In our analysis we assumed for each study that if the null
hypothesis was true for a SNP, the p-values were uniformly distributed,
that is, the z-score had a standard normal density. Efron (2008) lists several
reasons why the empirical null may be preferred over the theoretical null
distribution of the z-scores. The R package locfdr fits the empirical null
by truncated maximum likelihood or by fitting a quadratic to log fi near
the center. If in doubt about the theoretical null, the theoretical null may
be replaced with the empirical null in the empirical Bayes analysis. In our
analysis we estimated the conditional density of Zij given Hij ∈ {−1,0,1} in
order to discover replicated positive and negative associations. In future work
we intend to examine a more general parametrization of the associations.
The accuracy of the empirical Bayes analysis relies on the ability to es-
timate well the unknown parameters. We demonstrated in simulations that
the variability of the FDP decreased as the number of hypotheses increased.
In a simulation of realistic GWA studies we demonstrated that the empiri-
cal Bayes analysis produced inferences with a small FDP, despite the depen-
dency among the p-values within each study. A full Bayesian approach to the
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problem of GWA studies replicability is not possible, since we do not know
the true likelihood. To estimate the probabilities of each of the 3n configu-
rations of null and nonnull hypotheses, we used the product of the marginal
SNP likelihoods. In applications where the exact likelihood is known, it is
possible to use a full Bayesian approach, so that the suggested framework
for replicability analysis can be extended to account for the uncertainty of
the Bayes FDR estimates.
From a comparison of an empirical Bayes analysis with the analysis of
BHY09, we see that they may give similar inferences when the analysis
is aimed at discovering associations. However, for replicability the empirical
Bayes analysis discovers many more replicated associations than the analysis
of BHY09. In our analysis of the T2D studies, we removed the two studies
with an estimated fraction of null hypotheses of one from the empirical Bayes
analysis, since the alternative distribution could not be reliably estimated
for these two studies using the R package locfdr. However, these studies
are useful, as indicated by the fact that the analysis of BHY09 detected
more associations using all 6 studies than using only the 4 studies with an
estimated fraction of null hypotheses below one. How to best incorporate
these two studies into the empirical Bayes analysis is an open question.
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SUPPLEMENTARY MATERIAL
Supplementary material for replicability analysis for genome-wide associ-
ation studies (DOI: 10.1214/13-AOAS697SUPP; .pdf). Supplementary ma-
terial includes the proof of Proposition 3.1, additional numerical examples
that demonstrate the difference between optimal rejection regions and the
loss in power that occurs when the rejection region is chosen suboptimally
based on p-values, discussion of the necessity to specify the direction of the
alternative for estimation of the local Bayes FDRs, technical details of the
EM algorithm, the full table of results for the T2D example, the figure of
empirical z-scores for the T2D studies example, and an additional figure of
simulation results.
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